Have a personal or library account? Click to login
Comparison of 3D MRI with high sampling efficiency and 2D multiplanar MRI for contouring in cervix cancer brachytherapy Cover

Comparison of 3D MRI with high sampling efficiency and 2D multiplanar MRI for contouring in cervix cancer brachytherapy

Open Access
|Apr 2012

References

  1. Haie-Meder C, Pötter R, Van Limbergen E, Briot E, De Brabandere M, Dimopoulos J, et al. Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group (I): concepts and terms in 3D image based 3D treatment planning in cervix cancer brachytherapy with emphasis on MRI assessment of GTV and CTV. Radiother Oncol 2005; 74: 235-45.10.1016/j.radonc.2004.12.015
  2. Pötter R, Haie-Mader C, Van Limbergen E, Barillot I, De Brabandere M, Dimpoulos J, et al. Recommendations from gynaecological (GYN) GEC-ESTRO Working Group: (II): concepts and terms of 3D imaging, radiation physics, radiobiology, and 3D dose volume parameters. Radiother Oncol 2006; 78: 670-77.10.1016/j.radonc.2005.11.014
  3. Yadav P, Ramasubramanian V, Paliwal BR. Feasibility study on effect and stability of adaptive radiotherapy on kilovoltage cone beam CT. Radiol Oncol 2011; 45: 220-6.10.2478/v10019-011-0024-5
  4. Mayr NA, Montebello JF, Sorosky JI, Daugherty JS, Nguyen DL, Mardirossian G, et al. Brachytherapy management of the retroverted uterus using ultrasound-guided implant applicator placement. Brachytherapy 2005; 4: 24-9.10.1016/j.brachy.2004.10.007
  5. Sahinler I, Cepni I, Colpan D, Cepni K, Koksal S, Koca A, et al. Tandem application with transvaginal ultrasound guidance. Int J Radiat Oncol Biol Phys 2004; 59: 190-6.10.1016/j.ijrobp.2003.10.028
  6. Davidson MT, Yuen J, D'Souza D, Radwan JS, Hammond JA, Batchelar DL. Optimization of high-dose-rate cervix brachytherapy applicator placement: the benefits of intraoperative ultrasound guidance. Brachytherapy 2008; 7: 248-53.10.1016/j.brachy.2008.03.004
  7. Stock RG, Chan K, Terk M, Dewyngaert JK, Stone NN, Dottino P. A new technique for performing Syed -Neblett template interstitial implants for gynecologic malignancies using transrectal-ultrasound guidance. Int J Radiat Oncol Biol Phys 1997; 37: 819-25.10.1016/S0360-3016(96)00558-5
  8. Weitmann HD, Knocke TH, Waldhäusl C, Pötter R. Ultrasound-guided interstitial Brachytherapy in the treatment of advanced vaginal recurences from cervical and endometrial carcinoma. Strahlenther Onkol 2006; 182: 86-95.10.1007/s00066-006-1420-416447015
  9. Van Dyk S, Narayan K, Fisher R, Bernshaw D. Conformal brachytherapy planning for cervical cancer using transabdominal ultrasound. Int J Radiat Oncol Biol Phys 2009; 75: 64-70.10.1016/j.ijrobp.2008.10.05719250767
  10. Datta NR, Srivastava A, Maria Das KJ, Gupta A, Rastogi N. Comparative assessment of doses to tumor, rectum, and bladder as evaluated by orthogonal radiographs vs. computer enhanced computed tomography-based intracavitary brachytherapy in cervical cancer. Brachytherapy 2006; 5: 223-9.10.1016/j.brachy.2006.09.00117118314
  11. Shin KH, Kim TH, Cho JK, Kim JY, Park SY, Park SY, et al. CT-guided intracavitary radiotherapy for cervical cancer: Comparison of conventional point A plan with clinical target volume-based three-dimensional plan using dose volume parameters. Int J Radiat Oncol Biol Phys 2006; 64: 197-204.10.1016/j.ijrobp.2005.06.015
  12. Mai J, Rownd J, Erickson B. CT-guided high-dose-rate dose prescription for cervical carcinoma: the importance of uterine wall thickness. Brachytherapy 2002; 1: 27-35.10.1016/S1538-4721(02)00009-0
  13. Weitmann HD, Pötter R, Waldhäusl C, Nechvile E, Kirisits C, Knocke TH. Pilot study in the treatment of endometrial carcinoma with 3D image-based high-dose-rate brachytherapy using modified Heyman Packing: clinical experience and dose-volume histogram analysis. Int J Radiat Oncol Biol Phys 2005; 62: 468-78.10.1016/j.ijrobp.2004.10.013
  14. Pelloski CE, Palmer M, Chronowski GM, Jhingran A, Horton J, Eifel PJ. Comparison between CT-based volumetric calculations and ICRU reference-point estimates of radiation doses delivered to bladder and rectum during intracavitary radiotherapy for cervical cancer. Int J Radiat Oncol Biol Phys. 2005; 62: 131-7.10.1016/j.ijrobp.2004.09.059
  15. Sun LM, Huang EY, Ko SF, Wang CJ, Leung SW, Lin H, et al. Computer-tomography-assisted three-dimensional technique to assess rectal and bladder wall dose in intracavitary brachytherapy for uterine cervical cancer. Radiother Oncol 2004; 71: 333-7.10.1016/j.radonc.2004.03.001
  16. Schoeppel SL, Ellis JH, LaVigne ML, Schea RA, Roberts JA. Magnetic resonance imaging during intracavitary gynecologic brachytherapy. Int J Radiat Oncol Biol Phys 1992; 23: 169-74.10.1016/0360-3016(92)90557-X
  17. Tardivon AA, Kinkel K, Lartigau E, Masselot J, Gerbaulet AP, Vanel D. MR imaging during intracavitary brachytherapy of vaginal and cervical cancer: preliminary results. Radiographics 1996; 16: 1363-70.10.1148/radiographics.16.6.8946541
  18. Viswanathan AN, Cormack R, Holloway CL, Tanaka C, O'Farrell D, Devlin PM, et al. Magnetic resonance-guided interstitial therapy for vaginal recurrence of endometrial cancer. Int J Radiat Oncol Biol Phys 2006; 66: 91-9.10.1016/j.ijrobp.2006.04.037
  19. Wachter-Gerstner N, Wachter S, Reinstadler E, Fellner C, Knocke TH, Wambersie A, et al. Bladder and rectum dose defined from MRI based treatment planning for cervix cancer brachytherapy: comparison of dose-volume histograms for organ contours and organ wall, comparison with ICRU rectum and bladder reference point. Radiother Oncol 2003; 68: 269-76.10.1016/S0167-8140(03)00189-0
  20. Pötter R, Dimopoulos J, Georg P, Lang S, Waldhäusl C, Wachter-Gerstner N, et al. Clinical impact of MRI assisted dose volume adaptation and dose escalation in brachytherapy of locally advanced cervix cancer. Radiother Oncol 2007; 83: 148-55.10.1016/j.radonc.2007.04.01217531904
  21. Haie-Meder C, Chargari C, Rey A, Dumas I, Morice P, Magné N, et al. MRI-based low dose-rate brachytherapy experience in locally advanced cervical cancer patients initially treated by concomitant chemoradiotherapy. Radiother Oncol 2010; 96: 161-5.10.1016/j.radonc.2010.04.015
  22. De Brabandere M, Mousa AG, Nulens A, Swinnen A, Van Limbergen E. Potential of dose optimisation in MRI-based PDR brachytherapy of cervix carcinoma. Radiother Oncol 2008; 88: 217-26.10.1016/j.radonc.2007.10.026
  23. Lindegaard JC, Tanderup K, Nielsen SK, Haack S, Gelineck J. MRI-Guided 3D Optimization Significantly Improves DVH Parameters of Pulsed-Dose-Rate Brachytherapy in Locally Advanced Cervical Cancer. Int J Radiat Oncol Biol Phys 2008; 71: 756-64.10.1016/j.ijrobp.2007.10.032
  24. Boss EA, Barentsz JO, Massuger LF, Boonstra H. The role of MR imaging in invasive cervical carcinoma. Eur Radiol 2000; 10: 256-70.10.1007/s003300050042
  25. Subak LL, Hricak H, Powell CB, Azizi L, Stern JL. Cervical carcinoma: computed tomography and magnetic resonance imaging for preoperative staging. Obstet Gynecol 1995; 86: 43-50.10.1016/0029-7844(95)00109-5
  26. Hricak H, Gatsonis C, Coakley FV, Snyder B, Reinhold C, Schwartz LH, et al. Early invasive cervical cancer: CT and MR imaging in preoperative evaluation - ACRIN/GOG comparative study of diagnostic performance and interobserver variability. Radiology 2007; 245: 491-8.10.1148/radiol.245206198317940305
  27. Mitchell DG, Snyder B, Coakley F, Reinhold C, Thomas G, Amendola M, et al. Early invasive cervical cancer: tumor delineation by magnetic resonance imaging, computed tomography, and clinical examination, verified by pathologic results, in the ACRIN 6651/GOG 183 Intergroup Study. J Clin Oncol 2006; 24: 5687-94.10.1200/JCO.2006.07.479917179104
  28. Dimopoulos JC, Schard G, Berger D, Lang S, Goldner G, Helbich T, et al. Systematic evaluation of MRI findings in different stages of treatment of cervical cancer: potential of MRI on delineation of target, patho-anatomical structures and organs at risk. Int J Radiat Oncol Biol Phys 2006; 64: 1380-8.10.1016/j.ijrobp.2005.10.01716580496
  29. Podobnik J, Kocijancic I, Kovac V, Sersa I. 3T MRI in evaluation of asbestos-related thoracic diseases - preliminary results. Radiol Oncol 2010; 44: 92-6.10.2478/v10019-010-0027-7342368522933897
  30. Sofic A, Beslic S, Sehovic N, Caluk J, Sofic D. MRI in evaluation of perianal fistulae. Radiol Oncol 2010; 44: 220-7.10.2478/v10019-010-0046-4342371222933919
  31. Dimopoulos JC, Schirl G, Baldinger A, Helbich TH, Pötter R, et al. MRI assessment of cervical cancer for adaptive radiotherapy. Strahlenther Onkol 2009; 185: 282-7.10.1007/s00066-009-1918-719440666
  32. Hellebust TP, Kirisits C, Berger D, Pérez-Calatayud J, De Brabandere M, De Leeuw A, et al. Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group: Considerations and pitfalls in comissioning and applicator reconstruction in 3D image-based treatment planning of cervix cancer brachytherapy. Radiother Oncol 2010; 96: 153-60.10.1016/j.radonc.2010.06.00420663578
  33. Petric P, Hudej R, Music M. MRI assisted cervix cancer brachytherapy pre-planning, based on insertion of the applicator in para-cervical anaesthesia: preliminary results of a prospective study. J Contemp Brachyther 2009; 1: 163-9.
  34. Kouwenhoven E, Giezen M, Struikmans H. Measuring the similarity of target volume delineations independent of the number of observers. Phys Med Biol 2009; 54: 2863-73.10.1088/0031-9155/54/9/01819384002
  35. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurements. Lancet 1986; 1: 307-10.
  36. Bland JM, Altman DG. Measuring agreement in method comparison studies. Stat Methods Med Res 1999; 8: 135-60.10.1177/09622802990080020410501650
  37. Lin LI. A concordance correlation coefficient to evaluate reproducibility. Biometrics 1989; 45: 255-68.10.2307/2532051
  38. Georg D, Kirisits C, Hillbrand M, Dimopoulos J, Pötter R. Image-guided radio-therapy for cervix cancer: high-tech external beam therapy versus high-tech brachytherapy. Int J Radiat Oncol Biol Phys 2008; 71: 1272-8.10.1016/j.ijrobp.2008.03.03218495372
  39. Lichy MP, Wietek BM, Mugler JP 3rd, Horger W, Menzel MI, Anastasiadis A, et al. Magnetic resonance imaging of the body trunk using a single-slab, 3-dimensional, T2-weighted turbo-spin-echo sequence with high sampling efficiency (SPACE) for high spatial resolution imaging: initial clinical experiences. Invest Radiol 2005; 40: 754-60.10.1097/01.rli.0000185880.92346.9e16304477
  40. Fütterer JJ, Yakar D, Strijk SP, Barentsz JO. Preoperative 3T MR imaging of rectal cancer: local staging accuracy using a two-dimensional and three-dimensional T2-weighted turbo spin echo sequence. Eur J Radiol 2008; 65: 66-71.10.1016/j.ejrad.2007.11.02918164156
  41. Kim H, Lim JS, Choi JY, Park J, Chung YE, Kim MJ, et al. Rectal cancer: comparison of accuracy of local-regional staging with two- and three-dimensional preoperative 3-T MR imaging. Radiology 2010; 254: 485-92.10.1148/radiol.0909058720093520
  42. Rosenkrantz AB, Neil J, Kong X, Melamed J, Babb JS, Taneja SS, et al. Prostate cancer: Comparison of 3D T2-weighted with conventional 2D T2-weighted imaging for image quality and tumor detection. AJR Am J Roentgenol 2010; 194: 446-52.10.2214/AJR.09.321720093608
  43. Arizono S, Isoda H, Maetani YS, Hirokawa Y, Shimada K, Nakamoto Y, et al. High-spatial-resolution three-dimensional MR cholangiography using a high-sampling-efficiency technique (SPACE) at 3T: Comparison with the conventional constant flip angle sequence in healthy volunteers. J Magn Res Imaging 2008; 28: 685-90.10.1002/jmri.2148418777552
  44. Arizono S, Isoda H, Maetani YS, Hirokawa Y, Shimada K, Nakamoto Y, et al. High spatial resolution 3D MR cholangiography with high sampling efficiency technique (SPACE): Comparison of 3 T vs. 1.5 T. Eur J Radiol 2010; 73: 114-8.10.1016/j.ejrad.2008.08.00318834686
  45. Baumert B, Wörtler K, Steffinger D, Schmid GP, Schmidt GP, Reiser MF, Baur-Melnyk A. Assessment of the internal craniocervical ligaments with a new magnetic resonance imaging sequence: three dimensional turbo spin echo with variable flip-angle distribution (SPACE). Magn Res Imaging 2009; 27: 954-60.10.1016/j.mri.2009.01.01219282121
  46. Young JY, Yoon YC, Kwon JW, Ahn JH, Choe BK. Diagnosis of internal derangement of the knee at 3.0 T MR imaging: 3D isotropic intermediate-weighted versus 2D sequences. Radiology 2009; 253: 780-7.10.1148/radiol.253309045719789228
  47. Young JY, Yoon YC, Choi SH, Kwon JW, Yoo J, Choe BK. Three-dimensional isotropic shoulder MR arthrography for the diagnosis of labral lesions at 3.0 T. Radiology 2009; 250: 498-505.
  48. Gerbaulet A, Pötter R, Haie-Meder C. Cervix cancer. In: Gerbaulet A, Pötter R, Mazeron JJ, Meertens H, Van Limbergen E, editors. The GEC ESTRO handbook of brachytherapy. Brussels: European Society of Therapeutic Radiology and Oncology; 2002. p 301-63.
  49. Guedea F, Ellison T, Venselaar J, Borras JM, Hoskin P, Poetter R, et al. Overview of brachytherapy resources in Europe: a survey of patterns of care study for brachytherapy in Europe. Radiother Oncol 2007; 82: 50-4.10.1016/j.radonc.2006.11.01117150270
  50. Guedea F, Venselaar J, Hoskin P, Hellebust TP, Peiffert D, Londres B, et al. Patterns of care for brachytherapy in Europe: updated results. Radiother Oncol 2010; 97: 514-20.10.1016/j.radonc.2010.09.00920950878
  51. Viswanathan AN, Erickson BA. Three-dimensional imaging in gynaecological brachytherapy: a survey of the American Brachytherapy Society. Int J Radiat Oncol Biol Phys 2010; 76: 104-9.10.1016/j.ijrobp.2009.01.04319619956
  52. Dimopoulos JC, De Vos V, Berger D, Dumas I, Kirisits C, Shenfield CB, et al. Inter-observer comparison of target delineation for MRI-assisted cervical cancer brachytherapy: application of the GYN GEC-ESTRO recommendations. Radiother Oncol 2009; 91: 166-72.10.1016/j.radonc.2008.10.02319062118
  53. Lang S, Nulens A, Briot E, Kirisits C, De Brabandere M, Dumas I, Dimopoulos J, et al. Intercomparison of treatment concepts for MR image assisted brachytherapy of cervical carcinoma based on GYN GEC-ESTRO recommendations. Radiother Oncol 2006; 78: 185-93.10.1016/j.radonc.2006.01.00116466820
  54. Petric P, Dimopoulos J, Kirisits C, Berger D, Hudej R, Pötter R. Inter- and intraobserver variation in HR-CTV contouring: Intercomparison of transverse and paratransverse image orientation in 3D-MRI assisted cervix cancer brachytherapy. Radiother Oncol 2008; 89: 164-71.10.1016/j.radonc.2008.07.03018789829
  55. Rasch C, Barillot I, Remeijer P, Touw A, van Herk M, Lebesque JV. Definition of the prostate in CT and MRI: a multiobserver study. Int J Radiat Oncol Biol Phys 1999; 43: 57-66.10.1016/S0360-3016(98)00351-4
  56. Struikmans H, Warlam-Rodenhuis C, Stam T, Stapper G, Tersteeg RJ, Bol GH, et al. Interobserver variability of clinical target volume delineation of glandular breast tissue and of boost volume in tangential breast irradiation. Radiother Oncol 2005; 76: 293-9.10.1016/j.radonc.2005.03.029
  57. Hurkmans CW, Borger JH, Pieters BR, Russell NS, Jansen EP, Mijnheer BJ. Variability in target volume delineation on CT scans of the breast. Int J Radiat Oncol Biol Phys 2001; 50: 1366-72.10.1016/S0360-3016(01)01635-2
  58. Weiss E, Richter S, Krauss T, Metzelthin SI, Hille A, Pradier O, et al. Conformal radiotherapy planning of cervix carcinoma: differences in the delineation of target volume. A comparison between gynaecologic and radiation oncologists. Radiother Oncol 2003; 67: 87-95.10.1016/S0167-8140(02)00373-0
  59. Tanderup K, Hellebust TP, Lang S, Granfeldt J, Pötter R, Lindegaard JC, et al. Consequences of random and systematic reconstruction uncertainties in 3D image based brachytherapy in cervical cancer. Radiother Oncol 2008; 98: 156-63.10.1016/j.radonc.2008.06.01018692265
DOI: https://doi.org/10.2478/v10019-012-0023-1 | Journal eISSN: 1581-3207 | Journal ISSN: 1318-2099
Language: English
Page range: 242 - 251
Published on: Apr 11, 2012
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2012 Primoz Petric, Robert Hudej, Peter Rogelj, Mateja Blas, Barbara Segedin, Helena Logar, Johannes Dimopoulos, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons License.

Volume 46 (2012): Issue 3 (September 2012)